Related content

Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB₁ receptor antagonist

By Järbe Torbjörn   Harris Michele   Li Chen   Liu Qian   Makriyannis Alexandros  

Psychopharmacology, Vol. 177, Iss. 1-2, 2004-12 ,pp. : 35-45

Springer Publishing Company

Access to resources Recommend Favorite

Effects of the cannabinoid CB₁ receptor antagonist rimonabant on distinct measures of impulsive behavior in rats

By Pattij Tommy   Janssen Mieke   Schepers Inga   González-Cuevas Gustavo   Vries Taco   Schoffelmeer Anton  

Psychopharmacology, Vol. 193, Iss. 1, 2007-07 ,pp. : 85-96

Springer Publishing Company

Access to resources Recommend Favorite

Discriminative stimulus effects of the cannabinoid CB₁ antagonist SR 141716A in rhesus monkeys pretreated with ∆⁹-tetrahydrocannabinol

By McMahon Lance  

Psychopharmacology, Vol. 188, Iss. 3, 2006-10 ,pp. : 306-314

Springer Publishing Company

Access to resources Recommend Favorite

Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity?

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. : 2141-2144

Informa Healthcare

Access to resources Recommend Favorite

Will the new CB₁ cannabinoid receptor antagonist SR-147778 have advantages over rimonabant?

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 3, 2005-03 ,pp. : 339-342

Informa Healthcare

Access to resources Recommend Favorite